海外の治験の状況「1」での検索結果
36895件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Japan
- 2007-05-02
Not recruiting
- "Fun.Feel.Share" Lyrics-writing and Singing Show
- Mental Health Wellness 1;Mental Health Wellness 1;Mental Health Wellness 1
- Hong Kong
- 2017-09-04
Not recruiting
- Dose-response Study of Exendin-9,39 on Glucose Metabolism
- Pancreatic Effects of 9,39-Exendin and 9,36-GLP-1
- United States
- 2010-10-08
Not recruiting
- Joyful Adventure Day for Adolescents
- Mental Health Wellness 1;Mental Health Wellness 1;Mental Health Wellness 1
- Hong Kong
- 2017-11-27
Recruiting
- The Dose Response of Calcium Co-ingested With Protein on GLP-1 Concentrations
- GLP-1 Concentration
- United Kingdom
- 2019-01-21
Authorised
- Phase I study of concurrent with involved-field thoracic radiotherapy for inoperable non-squamous cell lung cancer, followed by both concurrent and maintenance Bevacizumab - Phase I study of Bevacizumab and thoracic radiotherapy for non-squamous cell lung cancer
- Patients with locally advanced (stages II-IIIB) non-small cell lung cancer who are eligible for high-dose radiotherapy following the completion of induction systemic chemotherapy.
- Netherlands
- 2006-07-28
Not Recruiting
- Phase I study on the feasibility of Nedaplatin plus S-1 combination therapy for squamous cell lung cancer.
- Squamous cell lung cancer
- Japan
- 2013-02-18
Not Recruiting
- Phase I clinical trial of HLA-A*2402 restricted epitope peptide cocktail therapy with S-1 for patients with unresectable advanced metastatic pancreatic cancer.
- pancreatic cancer
- Japan
- 2013-01-28
Recruiting
- A phase I study of alternate-day administration of S-1 plus leucovorin with bevacizumab in patients with refractory metastatic colorectal cancer.
- colorectal cancer
- Japan
- 2014-12-31
Recruiting
- Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
- Hereditary Hemorrhagic Telangiectasia;Idiopathic Vascular Ectasia
- United States
- 2014-11-06
Not recruiting
- Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
- Multiple Myeloma
- United States
- 2014-08-15
Not recruiting
- Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
- HIV
- United States
- 2014-07-24
Not Recruiting
- Phase I study of S-1 plus cisplatin and intraperitoneal administration of paclitaxel for gastric cacner with peritoneal metastasis
- gastric cancer with peritoneal metastasis
- Japan
- 2014-04-01
Recruiting
- Phase I study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 and intraperitoneal infusion of nafamostat mesilate for gastric cancer with peritoneal dissemination
- Gastric cancer with peritoneal dissemination
- Japan
- 2015-09-01
Not Recruiting
- Phase I study of irinotecan, S-1 and oxaliplatin in combination with radiation therapy in patients with advanced rectal cancer
- advanced rectal cancer
- Japan
- 2015-05-27
Recruiting
- Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
- Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
- Australia, France, Germany, Italy, Japan, Korea, Republic of, Spain, United States
- 2016-12-12
Not recruiting
- A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema
- Secondary Lymphedema
- Finland
- 2016-11-10
Not recruiting
- A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.
- Crohn's Disease;Crohn's Disease
- United States
- 2012-08-06
Not Recruiting
- A prospective comparison of direct renin inhibitor aliskiren and AT1 receptor blocker in hypertensive patients with chronic kidney disease(CKD).
- Hypertension Chronic kidney disease
- Japan
- 2012-08-04
Not Recruiting
- Phase I study of chemotherapy with gemcitabine, CDDP and S-1 for the patients with unresectable biliary tract cancer
- biliary tract cancer
- Japan
- 2012-07-12